Crossmark

Advances in personalized cancer immunotherapy

Crossref DOI link: https://doi.org/10.1007/s12282-016-0688-1

Published Online: 2016-03-21

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kakimi, Kazuhiro http://orcid.org/0000-0003-2631-3040
Karasaki, Takahiro

Matsushita, Hirokazu

Sugie, Tomoharu
Funding

Funding for this research was provided by:

a research program of the Project for Development of Innovative research on Cancer Therapeutics (P-Direct)

Ministry of Education, Culture, Sports, Science and Technology of Japan

The Japanese Breast Cancer Society
License Information

Text and Data Mining valid from 2016-03-21